The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics Corporation, a Silicon Valley surgical robotics company developing intelligent solutions to transform the field of urology, today announced ...
Procept makes the AquaBeam Robotic System, which is designed to be used in performing minimally invasive urology surgeries. The company's first-quarter results were positive, for the most part.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The FDA has granted a de novo request for Procept Biorobotics Inc.'s Aquabeam system for the resection and removal of prostate tissue for the treatment of lower urinary tract symptoms (LUTS) as a ...
On Monday, Piper Sandler, a financial services firm, increased its price target for Procept BioRobotics Corp (NASDAQ:PRCT) shares to $75.00, up from the previous target of $67.00. The firm also ...
In the latest quarter, 6 analysts provided ratings for PROCEPT BioRobotics (NASDAQ:PRCT), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...
Throughout the last three months, 7 analysts have evaluated PROCEPT BioRobotics (NASDAQ:PRCT), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of ...
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results